The obesity epidemic and its cardiovascular consequences

Area of Science:

• Cardiology
• Endocrinology
• Public Health

Background:

• Obesity is a global epidemic driven by obesogenic environments.
• Visceral fat accumulation is a critical factor in cardiovascular disease (CVD) risk.
• The World Health Organization (WHO) classifies obesity using body mass index (BMI).

Purpose of the Study:

• To review the association between obesity, visceral fat, and cardiovascular disease risk.
• To evaluate current understanding of metabolic syndrome and its relation to CVD.
• To assess the efficacy and potential of anti-obesity treatments.

Main Methods:

• Literature review of obesity, visceral fat, and cardiovascular outcomes.
• Analysis of diagnostic criteria for obesity and metabolic syndrome.
• Evaluation of current and emerging anti-obesity pharmacotherapies.

Main Results:

• Waist-to-hip ratio is a stronger predictor of cardiovascular events than BMI.
• Metabolic syndrome components are significant CVD risk predictors.
• Current anti-obesity drugs (orlistat, sibutramine) offer modest weight loss; rimonabant shows promise.
• Limited evidence supports insulin sensitizers for coronary artery disease patients.

Conclusions:

• Obesity is strongly linked to increased cardiovascular risk.
• Lifestyle modification is the primary management strategy for obesity.
• Anti-obesity medications may be beneficial for high-risk patients with comorbidities.